Literature DB >> 6272990

G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.

R M Fox, R F Kefford, E H Tripp, I W Taylor.   

Abstract

Cultured human T-cell leukemia lymphocytes have enhanced sensitivity to growth inhibition by deoxyadenosine. We have used flow cytometry to investigate the mechanism of deoxyadenosine toxicity in cultured T-leukemic cells. Comparative studies on deoxyadenosine-resistant Epstein-Barr virus-transformed B-lymphocyte cell lines were also performed. After exposure of T-cells to low concentrations of deoxyadenosine (3 microM), in the presence of an adenosine deaminase inhibitor (erythro-9-[3-(2-hydroxynonyl)]adenosine), accumulation of cells of cells with a G1 DNA content was demonstrated. In contrast, B-cell lines showed a similar degree of growth inhibition after exposure to 200 to 400 microM deoxyadenosine but were blocked in S phase. The T-cell G1 block was associated with a rise in the deoxyadenosine triphosphate pool, and both these phenomena were prevented by the addition of deoxycytidine. The biochemical mechanism of this G1 block induced by deoxyadenosine in T-cells is not understood.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272990

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.

Authors:  D S Duan; T Nagashima; T Hoshino; F Waldman; K Pawlak; W Sadee
Journal:  Biochem J       Date:  1990-06-15       Impact factor: 3.857

2.  Purinogenic lymphocytotoxicity: clues to a wider chemotherapeutic potential for the adenosine deaminase inhibitors.

Authors:  R F Kefford; R M Fox
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Relative sensitivity of human T cell subsets to deoxyadenosine toxicity.

Authors:  R E Callard; T M Ewing; R M Fox
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

4.  Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.

Authors:  G J Mann; R M Fox
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

5.  Lack of cross-resistance between cytosine arabinoside and a new halogenated nucleoside analogue, 2-bromo-2'-deoxyadenosine in human acute myeloid leukaemia cells.

Authors:  L B Pemble; M G Lihou; R L Blakley; G P Jamieson; P J Smith
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

6.  Regulation of ribonucleotide reductase activity in mammalian cells.

Authors:  J G Cory; A Sato
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

7.  Cell growth cycle block of T cell hybridomas upon activation with antigen.

Authors:  J D Ashwell; R E Cunningham; P D Noguchi; D Hernandez
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.